Home

Fehde gemäß monatlich rbd sequence Repertoire Kohärent neutral

Characterization of the receptor-binding domain (RBD) of 2019 novel  coronavirus: implication for development of RBD protein as a viral  attachment inhibitor and vaccine | Cellular & Molecular Immunology
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine | Cellular & Molecular Immunology

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2  receptor | Nature
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Nature

Sequence determinants of human-cell entry identified in ACE2-independent  bat sarbecoviruses: A combined laboratory and computational network science  approach - eBioMedicine
Sequence determinants of human-cell entry identified in ACE2-independent bat sarbecoviruses: A combined laboratory and computational network science approach - eBioMedicine

Receptor binding and complex structures of human ACE2 to spike RBD from  omicron and delta SARS-CoV-2 - ScienceDirect
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2 - ScienceDirect

The SARS Coronavirus S Glycoprotein Receptor Binding Domain: Fine Mapping  and Functional Characterization | Virology Journal | Full Text
The SARS Coronavirus S Glycoprotein Receptor Binding Domain: Fine Mapping and Functional Characterization | Virology Journal | Full Text

The proximal origin of SARS-CoV-2 | Nature Medicine
The proximal origin of SARS-CoV-2 | Nature Medicine

IJMS | Free Full-Text | Improved Binding Affinity of Omicron’s Spike  Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key  behind Its Increased Virulence
IJMS | Free Full-Text | Improved Binding Affinity of Omicron’s Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence

Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions: Trends  in Immunology
Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions: Trends in Immunology

Addgene: GST-RBD Sequences
Addgene: GST-RBD Sequences

Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2  receptor binding domain | Nature Communications
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain | Nature Communications

Potential for developing a SARS-CoV receptor-binding domain (RBD)  recombinant protein as a heterologous human vaccine against co
Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against co

JCI - Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high  degree of mutation resistance
JCI - Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance

Massive sequence perturbation of a small protein | PNAS
Massive sequence perturbation of a small protein | PNAS

SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison  and Potential Implications on Neutralizing Antibody and Vaccine Development  | bioRxiv
SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development | bioRxiv

Frontiers | Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits  Potent Neutralizing Responses in Mice and Non-human Primates
Frontiers | Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2  receptor | Nature
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Nature

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2  receptor | Nature
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Nature

nCoV-2019 Spike Protein Receptor Binding Domain Shares High Amino Acid  Identity With a Coronavirus Recovered from a Pangolin Viral Metagenomic  Dataset - nCoV-2019 Evolutionary History - Virological
nCoV-2019 Spike Protein Receptor Binding Domain Shares High Amino Acid Identity With a Coronavirus Recovered from a Pangolin Viral Metagenomic Dataset - nCoV-2019 Evolutionary History - Virological

Addgene: pcDNA3-SARS-CoV-2-S-RBD-8his
Addgene: pcDNA3-SARS-CoV-2-S-RBD-8his

Cells | Free Full-Text | Mechanistic Origin of Different Binding Affinities  of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2
Cells | Free Full-Text | Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2

IJMS | Free Full-Text | Role of the Pangolin in Origin of SARS-CoV-2: An  Evolutionary Perspective
IJMS | Free Full-Text | Role of the Pangolin in Origin of SARS-CoV-2: An Evolutionary Perspective

Engineering human ACE2 to optimize binding to the spike protein of SARS  coronavirus 2 | Science
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2 | Science

Structural and Functional Characterization of SARS-CoV-2 RBD Domains  Produced in Mammalian Cells | Analytical Chemistry
Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells | Analytical Chemistry

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2  receptor | Nature
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Nature

Researchers pinpoint spike protein regions as targets for passive and  active COVID-19 vaccines
Researchers pinpoint spike protein regions as targets for passive and active COVID-19 vaccines

Characterization of the receptor-binding domain (RBD) of 2019 novel  coronavirus: implication for development of RBD protein as a viral  attachment inhibitor and vaccine | Cellular & Molecular Immunology
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine | Cellular & Molecular Immunology